TITLE:
Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women

CONDITION:
Breast Neoplasms

INTERVENTION:
exemestane

SUMMARY:

      The purpose of this study is to find out if the two different formulations of exemestane
      (Aromasin), oral and injectable, are equivalent in terms of pharmacodynamics and
      pharmacokinetics, i.e., if ultimately both formulations have the same efficacy in
      postmenopausal women with metastatic breast cancer who have failed previous antiestrogens
      therapy and are equally safe.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  other diagnosed with breast cancer

          -  estrogen receptor positivity

          -  Postmenopausal status

          -  advanced disease

          -  progression to previous tamoxifen therapy

        Exclusion Criteria:

          -  more than 1 chemotherapy and / or more than 1 hormonotherapy for advanced disease

          -  previous hormonotherapy other than Tamoxifen
      
